JAMES CONRAD KAWANO
Pharmacy in Penn Valley, PA
License number
Pennsylvania RP030097L
Category
Pharmacy
Type
Pharmacist
Address
Address
Penn Valley, PA 19072
Personal information
See more information about JAMES CONRAD KAWANO at radaris.comName
Address
Phone
503 Valley View Rd, Merion, PA 19066
211 Hampden Ave, Narberth, PA 19072
Professional information
See more information about JAMES CONRAD KAWANO at trustoria.com
Method For Preventing Onset Of Hypertension Employing A Cholesterol Lowering Drug
Method For Preventing Onset Of Hypertension Employing A Cholesterol Lowering Drug
US Patent:
5593971, Jan 14, 1997
Filed:
May 22, 1995
Appl. No.:
8/445621
Inventors:
Werner Tschollar - Lawrenceville NJ
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Assignee:
E. R. Squibb & Sons, Inc. - Princeton NJ
International Classification:
A61K 3170, A61K 31675, A61K 3144, A61K 3140, A61K 3104, A61K 31235, A61K 31225, A61K 31195, A61K 3119, A61K 3110
US Classification:
514 39
Abstract:
A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
Method For Treating Hypertension Employing A Cholesterol Lowering Drug
Method For Treating Hypertension Employing A Cholesterol Lowering Drug
US Patent:
5461039, Oct 24, 1995
Filed:
Nov 1, 1993
Appl. No.:
8/143968
Inventors:
Werner Tschollar - Lawrenceville NJ
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Assignee:
E. R. Squibb & Sons, Inc. - Princeton NJ
International Classification:
A61K 3166, A61K 3140
US Classification:
514108
Abstract:
A method is provided for treating hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
Method For Preventing Onset Of Hypertension Employing A Cholesterol Lowering Drug
Method For Preventing Onset Of Hypertension Employing A Cholesterol Lowering Drug
US Patent:
5298497, Mar 29, 1994
Filed:
Jun 1, 1992
Appl. No.:
7/891243
Inventors:
Werner Tschollar - Lawrenceville NJ
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Cary S. Yonce - Newtown PA
James L. Bergey - Lansdale PA
James C. Kawano - Narberth PA
Assignee:
E. R. Squibb & Sons, Inc. - Princeton NJ
International Classification:
A61K 31675, A61K 3140, A61K 3135, A61K 3121
US Classification:
514 91
Abstract:
A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
Method For Preventing, Stabilizing Or Causing Regression Of Atherosclerosis Employing A Combination Of A Cholesterol Lowering Drug And An Ace Inhibitor
Method For Preventing, Stabilizing Or Causing Regression Of Atherosclerosis Employing A Combination Of A Cholesterol Lowering Drug And An Ace Inhibitor
US Patent:
6630502, Oct 7, 2003
Filed:
Dec 2, 1991
Appl. No.:
07/801207
Inventors:
James L. Bergey - Lansdale PA
Werner Tschollar - Lawrenceville NJ
Cary S. Yonce - Newtown PA
James C. Kawano - Narberth PA
Werner Tschollar - Lawrenceville NJ
Cary S. Yonce - Newtown PA
James C. Kawano - Narberth PA
Assignee:
E.R. Squibb Sons, Inc. - Princeton NJ
International Classification:
A61K 3140
US Classification:
514423, 514460, 514510, 514824, 514424
Abstract:
A method is provided for slowing the progression of atherosclerosis in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients by administering a combination of a cholesterol lowering drug such as pravastatin, and an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.